Oscar Health Inc
NYSE:OSCR

Watchlist Manager
Oscar Health Inc Logo
Oscar Health Inc
NYSE:OSCR
Watchlist
Price: 13.555 USD 4.67%
Market Cap: $3.6B

Wall Street
Price Targets

OSCR Price Targets Summary
Oscar Health Inc

Wall Street analysts forecast OSCR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OSCR is 16.002 USD with a low forecast of 8.08 USD and a high forecast of 24.15 USD.

Lowest
Price Target
8.08 USD
40% Downside
Average
Price Target
16.002 USD
18% Upside
Highest
Price Target
24.15 USD
78% Upside
Oscar Health Inc Competitors:
Price Targets
CNC
Centene Corp
11% Upside
KINS
Kingstone Companies Inc
32% Upside
LFG
Liberty Financial Group Ltd
17% Upside

Revenue
Forecast

91% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
91% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 5 years the compound annual growth rate for Oscar Health Inc's revenue is 91%. The projected CAGR for the next 3 years is 21%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-21%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OSCR's stock price target?
Price Target
16.002 USD

According to Wall Street analysts, the average 1-year price target for OSCR is 16.002 USD with a low forecast of 8.08 USD and a high forecast of 24.15 USD.

What is Oscar Health Inc's Revenue forecast?
Projected CAGR
21%

For the last 5 years the compound annual growth rate for Oscar Health Inc's revenue is 91%. The projected CAGR for the next 3 years is 21%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett